Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01647828 |
|---|---|
| Brief Title: | A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer (ALPINE) |
| First Submitted : | July 11, 2012 |
| First Submitted that Met QC Criteria : | July 19, 2012 |
| First Posted : | July 24, 2012 (Estimate) |
| Results First Submitted : | March 12, 2018 |
| Results First Submitted that Met QC Criteria : | January 19, 2023 |
| Results First Posted : | February 15, 2023 |
| Last Update Submitted that Met QC Criteria : | January 19, 2023 |
| Last Update Posted : | February 15, 2023 |